Catalent plans to close Belgium cell therapy sitenews2026-01-26T17:45:49+00:00January 26th, 2026|Endpoints News|
UK medicines agency seized 20M illegal drugs last year, including GLP-1snews2026-01-26T12:13:59+00:00January 26th, 2026|Endpoints News|
Novo’s Wegovy pill off to a solid start after just two weeks on marketnews2026-01-23T20:23:41+00:00January 23rd, 2026|Endpoints News|
EU kicks off one-year pilot to expedite multinational trialsnews2026-01-23T19:24:15+00:00January 23rd, 2026|Endpoints News|
ACIP members depict diverging goals after schedule changenews2026-01-23T18:24:41+00:00January 23rd, 2026|Endpoints News|
F2G CEO outlines biotech’s FDA resubmission plans, funding and expansionnews2026-01-23T16:38:10+00:00January 23rd, 2026|Endpoints News|
Sanofi’s Phase 3 eczema data cloud hopes for potential immunology blockbusternews2026-01-23T15:39:18+00:00January 23rd, 2026|Endpoints News|
Lilly was the only pharma bidder for Ventyxnews2026-01-23T12:20:13+00:00January 23rd, 2026|Endpoints News|
Insurance CEOs defend their businesses at House hearingnews2026-01-23T12:10:15+00:00January 23rd, 2026|Endpoints News|
High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’ news2026-01-22T19:53:16+00:00January 22nd, 2026|Endpoints News|
